Litcius/Paper detail

Green formulation of Ag nanoparticles by Hibiscus rosa-sinensis: Introducing a navel chemotherapeutic drug for the treatment of liver cancer

Le Lü, Ziyun Zhuang, Meng Fan, Bingli Liu, Yi Yang, Jingjing Huang, Xuanbo Da, Jiantao Mo, Qiao‐Xin Li, Hongwei Lü

2021Arabian Journal of Chemistry17 citationsDOIOpen Access PDF

Abstract

An eco-friendly biosynthesized Ag NPs immobilized Hibiscus rosa-sinensis extract has been introduced. The as-prepared nanoparticles were characterized using UV–Vis, SEM, and FT-IR analysis. In the FT-IR test, the presence of many antioxidant compounds with related bonds caused the excellent condition for reducing of silver in the silver nanoparticles. In UV–Vis, the clear peak in the wavelength of 428 nm indicated the formation of silver nanoparticles. The synthesized nanoparticles had very low cell viability and high anti-liver cancer activities dose-dependently against pleomorphic hepatocellular carcinoma (SNU-387), hepatic ductal carcinoma (LMH/2A), morris hepatoma (McA-RH7777), and novikoff hepatoma (N1-S1 Fudr) cell lines without any cytotoxicity on the normal cell line (HUVEC). The synthesized nanoparticles inhibited half of the DPPH molecules in the concentration of 78 µg/mL. Perhaps notable anti-liver cancer activities of the synthesized nanoparticles against common liver cancer cell lines are linked to their antioxidant activities.

Topics & Concepts

ChemistryLiver cancerNanoparticleNuclear chemistryDPPHCytotoxicityViability assayAntioxidantHepatocellular carcinomaSilver nanoparticleCancer cellHibiscusHepatic carcinomaCell cultureCancerNanotechnologyBiochemistryApoptosisCancer researchIn vitroBotanyMaterials scienceBiologyGeneticsMoringa oleifera research and applicationsNanoparticles: synthesis and applicationsNigella sativa pharmacological applications
Green formulation of Ag nanoparticles by Hibiscus rosa-sinensis: Introducing a navel chemotherapeutic drug for the treatment of liver cancer | Litcius